Future of the Inactivated Vaccines Market: Strategic Analysis and Forecast to 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Inactivated Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been a consistent expansion in the market size for inactivated vaccines. The projections suggest a growth from $6.19 billion in 2024 to $6.44 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.0%. Factors such as eradication attempts against polio, influenza vaccination initiatives, the rise of new infectious diseases, and regulatory approvals have fueled the growth witnessed in the historical period.

Inactivated Vaccines Market Size Forecast: What's the Projected Valuation by 2029?
The market size for inactivated vaccines is projected to experience a consistent increase in the coming years. By 2029, it is estimated to reach $7.75 billion, with a compounded annual growth rate (CAGR) of 4.7%. Factors contributing to this expected growth include preparation for pandemics, broadening vaccine coverage, progress in biomanufacturing, and initiatives aimed at health equity. Key trends forecasted for this period encompass mRNA vaccine platforms, combined vaccines, thermostable vaccines, and the use of digital vaccine passports.

View the full report here:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

What Are the Drivers Transforming the Inactivated Vaccines Market?
The mounting incidence of infectious ailments is projected to fuel the expansion of the inactivated vaccine market. Infectious diseases, prompted by pathogens including bacteria, viruses, fungi, or parasites, can transmit from one individual to another, causing a variety of symptoms and health problems. One example is Tuberculosis. The inactivated vaccines that utilize non-living pathogens to trigger an immune reaction, effectively guard against diseases such as polio, hepatitis A, and influenza. According to an article by the Centers for Disease Control and Prevention from November 2023, there was a rise in tuberculosis patients in the USA, from 8,320 in 2022 to 9,615 in 2023 which signifies an increase of 1,295 cases. Hence, the rising prevalence of infectious diseases is promoting the growth of the inactivated vaccine market. Market Driver for Inactivated Vaccines: Growth Bolstered by Rising Immunization Campaigns

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

What Long-Term Trends Will Define the Future of the Inactivated Vaccines Market?
Leading firms in the inactivated vaccines market are developing sophisticated and ground-breaking inactivated vaccines to maintain their market position. These types of vaccines include inactivated virus particles, bacteria, or other pathogens that have been cultured and subsequently neutralized to eliminate their disease-causing capabilities. For instance, in January 2022, GSK PLC, a pharmaceutical and biotechnology firm based in the UK, launched a novel inactivated vaccine named Shingrix to help protect against shingles (Herpes zoster). Shingrix, a non-live, recombinant subunit adjuvanted vaccine, is given intramuscularly in two doses. Initially, the vaccine was recommended for people aged 50 and over, but it has now been extended to those aged 18 and above who may have an increased risk of getting shingles due to compromised or suppressed immunity resulting from a certain disease or therapy.

Which Segments in the Inactivated Vaccines Market Offer the Most Profit Potential?
The inactivated vaccines market covered in this report is segmented -

1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp

Which Firms Dominate the Inactivated Vaccines Market by Market Share and Revenue in 2025?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

Which Regions Offer the Highest Growth Potential in the Inactivated Vaccines Market?
North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13018

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.